Recent articles
Weekly Cannabis Stock News: Canopy Growth's Ugly Q1
The bellwether marijuana stock delivered a very disappointing quarter, and Tilray's latest wasn't much better. Aurora Cannabis, meanwhile, gets to borrow a bit more money.
Aurora Cannabis Expands Credit Facility by 80%
The addition of new lenders will give the company access to around CA$360 million.
After Hours: NVIDIA Notches Q2 Beats, GE CEO Buys Stock Amid Company Fraud Allegations
The computer graphics card maker sees notable drops in fundamentals but still exceeds estimates, and GE's leader loads up on company stock.
After Hours: Warren Buffett Reveals New Investments, Cisco Sinks on Q4 Results
Berkshire Hathaway plows some of its considerable cash pile into shares of Amazon.com, while Cisco disappoints the market.
Canopy Growth Q1 Misses on Revenue, Earnings
The prominent marijuana stock trades down on news of its worse-than-expected results.
After Hours: FTC Considering Tech Giant Breakups, The RealReal Beats on Q2 Estimates
Not for the first time, America's famous tech behemoths seem to be in regulators' crosshairs; The RealReal, meanwhile, posts its first quarterly figures as a publicly traded company.
Tilray Q2 Beats on Revenue, Misses on Earnings
The Canadian grower and distributor posts a sharp top-line increase thanks to relatively new product categories.
After Hours: Yum! Brands Gets a New CEO, Verizon Sells Tumblr
The restaurant chain operator will start 2020 with a new leader, while Verizon unloads one of its well-known internet assets.
CannTrust Reveals New Notice of Violations
In a fresh controversy, the embattled Canadian grower is cited for a series of transgressions at its Vaughan, Ontario, facility.
Weekly Cannabis Stock News: GW Pharmaceuticals Blows Past Estimates
Quarterly results, more quarterly results, a new buyout and a potentially new Nasdaq marijuana stock -- last week was far from boring in the cannabis industry.
Canopy Growth Buys Out Cannabis Research Joint Venture
The ambitious marijuana company continues to strengthen its medical cannabis business.
After Hours: Uber's Big Q2 Whiffs, Broadcom and Symantec Seal Their Deal
The ridesharing giant posts a $5 billion-plus net loss, while the two big IT companies finally sign on the dotted line.
Cronos Group's Q2 Trounces Estimates
The cannabis company more than triples its revenue figure.
After Hours: Broadcom and Symantec Reportedly Nearing Deal, Lyft Smashes Q2 Estimates
Two recently estranged tech companies are apparently ready to (finally) make a deal, while Lyft delivers a pleasant upside surprise.
GW Pharmaceuticals Q2 Results Crush Revenue Estimates; Stock Soars
The company's fundamentals got a major boost from its star drug, Epidiolex.
After Hours: Disney's Q3 Misses, Hertz's Q2 Trounces
Or, A Tale of Two Quarterly Earnings Reports.
Aurora Cannabis Up on Encouraging Q4 Preliminary Results
The company estimates that it will post significant top-line growth for the quarter.
After Hours: Take-Two and Shake Shack Triumph Over Estimates
Not everything in the stock market was bad on Monday -- here are two companies that are gaining in post-market trading.
Weekly Cannabis Stock News: Scotts Miracle-Gro Keeps Growing, Cronos Buys Lord Jones
The supplier to the cannabis stars posts strong quarterly results, as does Aphria. Meanwhile, Cronos goes shopping at the beauty counter.
Cronos Group Acquires CBD Beauty Line Producer
The company is paying around $300 million for the owner of the Lord Jones line of CBD products.